When: Confirmed close above $200.70 (10 EMA) on rising volume with RSI >35

Then: Partial add at half-size of trigger A

When: Confirmed close above $208 with MACD histogram contracting on volume >4M

Then: Upgrade to Hold or modest Overweight; full structural re-engagement requires Q3 2026 beat-and-raise

HOLD position; do not add at $195; stop at $190; wait for confirmation before adding new capital at either $185-190 with reset momentum OR reclaim of 50 SMA at $207.90 with rising RSI

• Stock fallen 13.7% from August peak to current $195 level, not behaving defensively despite 0.287 beta
• Price sitting just 1.4% above 200 SMA at $192.48 - described as 'knife edge' with multiple potential catalysts for breakdown (contract award disappointment, CR, hot CPI)
• MACD still negative and expanding bearish with histogram red for nearly a month; 10 EMA rolling over at $200.70; price $12.56 below 50 SMA
• ATR of $4.07 means $190 stop is less than 2x ATR below entry - tight stop in deteriorating tape
• AR of $14.7B represents working capital drag; FCF could partially reverse if receivables continue outpacing collections despite 2025 doubling from $3.9B to $7.45B
• Multiple of 34.5x TTM P/E and 24.9x forward P/E already pricing in best-case scenario requiring everything to go right
• 10Y at 5% with recession probability ticking up; industrials lagging S&P by 8.3 percentage points; lower highs and lower lows forming
• Geopolitical escalation could reverse and actual kinetic conflict disrupting operations is tail risk
• Conservative approach is to require margin of safety - entering at $190 limits losses if bull case partially fails

→ vs aggressive: Challenges 'distributions end' and ATR compression as signal of seller exhaustion: ATR compression indicates measured selling, not that selling is over; orderly decline from $226 to $195 can continue to $185 or $170; reading absence of panic as presence of accumulation is a dangerous leap

→ vs aggressive: Challenges 200 SMA at $192.48 as 'gift': reframes as 'knife edge' - stock is only 1.4% above its most important long-term trend line; one catalyst (contract disappointment, CR, hot CPI) causes failure and 'textbook mean-reversion launch point' becomes breakdown entry

→ vs aggressive: Challenges AR divergence framing as just structural billing-mix: $14.7B AR is working capital drag; if revenue growth slows while receivables compound, FCF inflection could partially reverse; quality of FCF story less certain than claimed

→ vs aggressive: Challenges PEG of 0.65 as underestimating growth: multiple already prices in best-case scenario where everything goes right (revenue inflects, margins expand, GTF scales, no overruns, no CR delays, no de-escalation); requires margin of safety

→ vs aggressive: Challenges geopolitical tailwind as durable: NATO commitments are aspirational phased over years; budgets subject to appropriations and CRs; escalation could de-escalate compressing urgency premium; actual kinetic conflict disrupts operations and supply chains

→ vs aggressive: Challenges beta of 0.287 as indicating defensive behavior: beta measures historical price correlation, not idiosyncratic risk; RTX-specific bad news (GTF inspection finding, cost overrun, test failure) would hit regardless of beta; stock already fell 13.7% showing it has been hit

RATIFY THE HOLD DECISION: Maintain the current position at $195.34 without adding fresh capital at current levels. Stop placement should be tightened to $191.50. Consider a tiered entry approach with partial adds at 10 EMA reclaim ($200.70) and full adds at either the flush zone ($185-190) or 50 SMA reclaim ($207.90). Implement dynamic position sizing that scales to 7-8% on confirmed technical signals or down to 3% on 200 SMA failure.

• 200 SMA support at $192.48 represents critical technical level; stock closed at $195.34 with intraday low of $194.01, less than $2 above this support
• ATR compression from $5.66 to $4.07 indicates orderly selling but doesn't confirm selling exhaustion; MACD still negative with expanding bearish histogram
• Stop should be set at $191.50 (just below 200 SMA) rather than $190, providing approximately 2x ATR buffer against entry price
• Partial add trigger: 10 EMA reclaim at $200.70 on rising volume with RSI moving above 35 (half-size position)
• Primary add triggers remain $185-190 flush zone with reset momentum, or reclaim of 50 SMA at $207.90 with rising RSI
• Allowance for doubtful accounts ticked up from $289M to $340M; AR growth of 34% vs 10% revenue growth is a yellow flag warranting monitoring
• Operating cash flow of $10.57B running well ahead of net income of $6.73B supports earnings quality argument
• Beta of 0.287 measures historical correlation but doesn't protect against company-specific risk (GTF issues, program cost overruns, test failures)
• 10-year yield briefly pierced 5%; Polymarket shows 94% probability of zero Fed cuts in 2026; US recession probability at 10% with 3pp weekly jump
• Industrial sector lagging S&P 500 by 8.3 percentage points over six months shows late-cycle stress signals
• Net debt deleveraging from $37.2B in 2023 to $30.5B in 2025; FCF nearly doubled from $3.92B to $7.45B
• Institutional news flow constructive: $50M Forest expansion for NGJ-MB EW systems, $472M Chinook avionics contract, Xcimer laser-fusion partnership
• $29B deferred revenue provides multi-year visibility; GTF aftermarket scaling supports long-term thesis
• Absence of Reddit retail engagement on $263B market cap name during 13.7% drawdown argues for measured positioning rather than aggressive accumulation
• Long-term thesis and near-term entry timing are separate questions; strength in fundamentals doesn't validate aggressive near-term entry

→ vs aggressive: ATR compression from $5.66 to $4.07 indicates orderly selling but does not confirm selling is over; MACD still negative with expanding histogram shows trend in progress, not exhaustion. Reading absence of panic as presence of accumulation is unsupported inference

→ vs aggressive: 200 SMA at $192.48 is a 'knife edge' with stock $195.34 and ATR of $4.07; single down day could pierce support. Asking to bet bottom is in within 1.4% of most important chart support is not asymmetric—it resembles a coin flip with 13.7% peak-to-trough drawdown already materialized

→ vs aggressive: Beta of 0.287 measures historical correlation and doesn't protect against company-specific risks (GTF inspection findings, program cost overruns, missile defense test failures). The 13.7% drop in under a month is repricing, not defensive behavior. Anchoring on backward-looking beta while ignoring actual price action is flawed reasoning

→ vs aggressive: AR growth rate of 34% vs 10% revenue growth is 'real' and could compress FCF if collections slow in 2026; the jump from 'structurally driven billing mix' to 'quality of earnings improving' overstates what the data supports

→ vs conservative: Waiting for confirmation is not a free option; confirmation patterns take 2-4 weeks. A single positive defense contract announcement, favorable CPI print, or geopolitical escalation could reclaim 50 SMA at $207.90 before confirmation, leaving conservative analyst buying at materially higher price

→ vs conservative: Defense contractors benefit from actual kinetic conflict through demand surge for missile replenishment (Patriot interceptors, AMRAAM, Tomahawk); relationship between geopolitics and RTX revenue is more complex than 'only benefit from tension, hurt by actual conflict' framing